346 related articles for article (PubMed ID: 21987773)
1. Genomic RNA editing and its impact on Ebola virus adaptation during serial passages in cell culture and infection of guinea pigs.
Volchkova VA; Dolnik O; Martinez MJ; Reynard O; Volchkov VE
J Infect Dis; 2011 Nov; 204 Suppl 3():S941-6. PubMed ID: 21987773
[TBL] [Abstract][Full Text] [Related]
2. RNA Editing of the GP Gene of Ebola Virus is an Important Pathogenicity Factor.
Volchkova VA; Dolnik O; Martinez MJ; Reynard O; Volchkov VE
J Infect Dis; 2015 Oct; 212 Suppl 2():S226-33. PubMed ID: 26138826
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of guinea pig-adapted variants of Ebola virus.
Volchkov VE; Chepurnov AA; Volchkova VA; Ternovoj VA; Klenk HD
Virology; 2000 Nov; 277(1):147-55. PubMed ID: 11062045
[TBL] [Abstract][Full Text] [Related]
4. VP24 is a molecular determinant of Ebola virus virulence in guinea pigs.
Mateo M; Carbonnelle C; Reynard O; Kolesnikova L; Nemirov K; Page A; Volchkova VA; Volchkov VE
J Infect Dis; 2011 Nov; 204 Suppl 3():S1011-20. PubMed ID: 21987737
[TBL] [Abstract][Full Text] [Related]
5. Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity.
Volchkov VE; Volchkova VA; Muhlberger E; Kolesnikova LV; Weik M; Dolnik O; Klenk HD
Science; 2001 Mar; 291(5510):1965-9. PubMed ID: 11239157
[TBL] [Abstract][Full Text] [Related]
6. Ebola virus (EBOV) VP24 inhibits transcription and replication of the EBOV genome.
Watanabe S; Noda T; Halfmann P; Jasenosky L; Kawaoka Y
J Infect Dis; 2007 Nov; 196 Suppl 2():S284-90. PubMed ID: 17940962
[TBL] [Abstract][Full Text] [Related]
7. Genetic Changes at the Glycoprotein Editing Site Associated With Serial Passage of Sudan Virus.
Alfson KJ; Avena LE; Beadles MW; Menzie H; Patterson JL; Carrion R; Griffiths A
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S295-304. PubMed ID: 25920319
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of Ebola virus VP24 impairs viral nucleocapsid assembly and prevents virus replication.
Mateo M; Carbonnelle C; Martinez MJ; Reynard O; Page A; Volchkova VA; Volchkov VE
J Infect Dis; 2011 Nov; 204 Suppl 3():S892-6. PubMed ID: 21987766
[TBL] [Abstract][Full Text] [Related]
9. Soluble Glycoprotein Is Not Required for Ebola Virus Virulence in Guinea Pigs.
Hoenen T; Marzi A; Scott DP; Feldmann F; Callison J; Safronetz D; Ebihara H; Feldmann H
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S242-6. PubMed ID: 25957965
[TBL] [Abstract][Full Text] [Related]
10. Ebola Virus GP Gene Polyadenylation Versus RNA Editing.
Volchkova VA; Vorac J; Repiquet-Paire L; Lawrence P; Volchkov VE
J Infect Dis; 2015 Oct; 212 Suppl 2():S191-8. PubMed ID: 25838269
[TBL] [Abstract][Full Text] [Related]
11. An Improved Reverse Genetics System to Overcome Cell-Type-Dependent Ebola Virus Genome Plasticity.
Tsuda Y; Hoenen T; Banadyga L; Weisend C; Ricklefs SM; Porcella SF; Ebihara H
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S129-37. PubMed ID: 25810440
[TBL] [Abstract][Full Text] [Related]
12. Genetic factors of Ebola virus virulence in guinea pigs.
Subbotina E; Dadaeva A; Kachko A; Chepurnov A
Virus Res; 2010 Oct; 153(1):121-33. PubMed ID: 20654661
[TBL] [Abstract][Full Text] [Related]
13. Release of viral glycoproteins during Ebola virus infection.
Volchkov VE; Volchkova VA; Slenczka W; Klenk HD; Feldmann H
Virology; 1998 May; 245(1):110-9. PubMed ID: 9614872
[TBL] [Abstract][Full Text] [Related]
14. VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in mice.
Enterlein S; Warfield KL; Swenson DL; Stein DA; Smith JL; Gamble CS; Kroeker AD; Iversen PL; Bavari S; Mühlberger E
Antimicrob Agents Chemother; 2006 Mar; 50(3):984-93. PubMed ID: 16495261
[TBL] [Abstract][Full Text] [Related]
15. A reconstituted replication and transcription system for Ebola virus Reston and comparison with Ebola virus Zaire.
Boehmann Y; Enterlein S; Randolf A; Mühlberger E
Virology; 2005 Feb; 332(1):406-17. PubMed ID: 15661171
[TBL] [Abstract][Full Text] [Related]
16. Modeling Ebola Virus Genome Replication and Transcription with Minigenome Systems.
Cressey T; Brauburger K; Mühlberger E
Methods Mol Biol; 2017; 1628():79-92. PubMed ID: 28573612
[TBL] [Abstract][Full Text] [Related]
17. Reverse genetic generation of recombinant Zaire Ebola viruses containing disrupted IRF-3 inhibitory domains results in attenuated virus growth in vitro and higher levels of IRF-3 activation without inhibiting viral transcription or replication.
Hartman AL; Dover JE; Towner JS; Nichol ST
J Virol; 2006 Jul; 80(13):6430-40. PubMed ID: 16775331
[TBL] [Abstract][Full Text] [Related]
18. Serine-Arginine Protein Kinase 1 Regulates Ebola Virus Transcription.
Takamatsu Y; Krähling V; Kolesnikova L; Halwe S; Lier C; Baumeister S; Noda T; Biedenkopf N; Becker S
mBio; 2020 Feb; 11(1):. PubMed ID: 32098814
[TBL] [Abstract][Full Text] [Related]
19. Evidence against an important role for infectivity-enhancing antibodies in Ebola virus infections.
Geisbert TW; Hensley LE; Geisbert JB; Jahrling PB
Virology; 2002 Feb; 293(1):15-9. PubMed ID: 11853394
[TBL] [Abstract][Full Text] [Related]
20. Role of VP30 phosphorylation in the Ebola virus replication cycle.
Martinez MJ; Volchkova VA; Raoul H; Alazard-Dany N; Reynard O; Volchkov VE
J Infect Dis; 2011 Nov; 204 Suppl 3():S934-40. PubMed ID: 21987772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
